20/20 Biolabs Inc. (AIDX)
$0.38+0.00%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 1.54
- P/E (TTM)
- -0.46
- Short % float
- 1.06%
- Days to cover
- 1.0
- SI change
- -3.5%
- 1W
- +0.00%
- 1M
- -29.63%
- vs SPY 1W
- -1.16%
- vs SPY 1M
- -32.62%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on AIDX?
- LOPJLB’s latest quantitative signal on 20/20 Biolabs Inc. (AIDX) is SELL. Signals are updated daily.
- What market regime is AIDX in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does 20/20 Biolabs Inc. (AIDX) do?
- 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator…